- Home
- IMTE vs DRMA Comparison
IMTE vs DRMA Comparison
Compare IMTE & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- DRMA
- Stock Information
- Founded
- IMTE 2008
- DRMA 2014
- Country
- IMTE Malaysia
- DRMA United States
- Employees
- IMTE N/A
- DRMA N/A
- Industry
- IMTE Consumer Electronics/Appliances
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- DRMA Health Care
- Exchange
- IMTE Nasdaq
- DRMA Nasdaq
- Market Cap
- IMTE 5.3M
- DRMA 6.1M
- IPO Year
- IMTE N/A
- DRMA 2021
- Fundamental
- Price
- IMTE $1.26
- DRMA $1.25
- Analyst Decision
- IMTE
- DRMA Strong Buy
- Analyst Count
- IMTE 0
- DRMA 1
- Target Price
- IMTE N/A
- DRMA $6.00
- AVG Volume (30 Days)
- IMTE 6.4K
- DRMA 465.7K
- Earning Date
- IMTE 03-04-2025
- DRMA 03-20-2025
- Dividend Yield
- IMTE N/A
- DRMA N/A
- EPS Growth
- IMTE N/A
- DRMA N/A
- EPS
- IMTE N/A
- DRMA N/A
- Revenue
- IMTE $123,337.00
- DRMA N/A
- Revenue This Year
- IMTE N/A
- DRMA N/A
- Revenue Next Year
- IMTE N/A
- DRMA N/A
- P/E Ratio
- IMTE N/A
- DRMA N/A
- Revenue Growth
- IMTE 4.75
- DRMA N/A
- 52 Week Low
- IMTE $1.06
- DRMA $1.00
- 52 Week High
- IMTE $3.84
- DRMA $7.62
- Technical
- Relative Strength Index (RSI)
- IMTE 47.80
- DRMA 52.68
- Support Level
- IMTE $1.21
- DRMA $1.00
- Resistance Level
- IMTE $1.30
- DRMA $1.28
- Average True Range (ATR)
- IMTE 0.07
- DRMA 0.09
- MACD
- IMTE -0.00
- DRMA 0.01
- Stochastic Oscillator
- IMTE 30.16
- DRMA 74.07
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.